LOS ANGELES, July 25, 2011 /PRNewswire/ -- Bariatric surgery is recommended by IDF, the International Diabetes Foundation, for obese patients with type 2 diabetes. According to a new IDF position paper, bariatric surgeries for these obese patients can reduce health care costs in the long run. According to IDF, the surgery often normalizes blood glucose levels and reduces or even eliminates the need for medication. LAP-BAND® Adjustable Gastric Banding system is the original alternative to more invasive gastric bypass surgery and has a history of proven success in helping patients reach their weight loss goals for the long term.
According to an estimate by IDF, for a person in United States who is diagnosed at the age 50, the lifetime cost of diabetes is $172,000, and for a person diagnosed at age 30 this cost would be $305,000. More than 60% of these costs are incurred in the first decade after diagnosis.
With the new IDF guidelines, patients with type 2 diabetes would warrant bariatric surgery when their BMI is higher than 35; or when their BMI is between 30 and 35 when their diabetes cannot be controlled by lifestyle changes and medication. IDF has said that trials are needed to compare surgical procedures. However, the new recommended indications for bariatric surgery for patients who are both diabetic and obese match those announced by US Food and Drug Administration (FDA) for expanded use of LAP-BAND® system.
LAP-BAND® reduces the amount of the food the stomach can hold at one time, which helps to gradually lose weight and keep it off. LAP-BAND® has been proven to result in steady and healthy weight loss and to help patients keep the weight off for a longer period of time compared to non-surgical treatments.
LAP-BAND® Adjustable Gastric Banding system is the only FDA-approv